Ost-müük Tyme Technologies, Inc. - TYME CFD
Lisa lemmikuks- Kokkuvõte
- Ajaloolised andmed
- Sündmused
- Tuluaruanne
- Bilanss
- Rahavood
- Omand
Hinnavahe | 0.05 | ||||||||
Pika positsiooni ööpäeva tasu
Long position overnight fee
Mine platvormile | -0.024068% | ||||||||
Lühikese positsiooni ööpäeva tasu
Short position overnight fee
Mine platvormile | 0.001846% | ||||||||
Ööpäeva tasu aeg | 21:00 (UTC) | ||||||||
Min kauplemise kogus | 1 | ||||||||
Valuuta | USD | ||||||||
Tagatis | 20% | ||||||||
Aktsiabörs | United States of America | ||||||||
Kauplemise vahendustasu | 0% |
*Information provided by Capital.com
Eelmine sulgemine* | N/A |
Avatud* | 0.49 |
Aastane muutus* | -2% |
Päeva ulatus* | 0.48 - 0.52 |
52 nädala ulatus | 0.22-1.14 |
Keskmine maht (10 päeva) | 1.42M |
Keskmine maht (3 kuud) | 28.72M |
Turukapitalisatsioon | 53.50M |
P/E suhtarv | -100.00K |
Ringluses olevad aktsiad | 172.21M |
Tulu | N/A |
EPS | -0.14 |
Dividendid (% kasumist) | N/A |
Beeta | 0.90 |
Järgmine tuluaruande kuupäev | Nov 7, 2022 |
Kõigi andmete allikas on Refinitiv, välja arvatud tärniga märgitud, kus *-ga andmed on esitanud Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Sulgemishind | Change (%) | Avamishind | High | Low |
---|---|---|---|---|---|---|
Jan 26, 2022 | 0.38 | 0.00 | 0.00% | 0.38 | 0.38 | 0.38 |
Jan 25, 2022 | 0.50 | 0.02 | 4.17% | 0.48 | 0.52 | 0.48 |
Jan 24, 2022 | 0.50 | 0.03 | 6.38% | 0.47 | 0.52 | 0.45 |
Jan 21, 2022 | 0.52 | -0.01 | -1.89% | 0.53 | 0.54 | 0.51 |
Jan 20, 2022 | 0.53 | -0.03 | -5.36% | 0.56 | 0.57 | 0.52 |
Jan 19, 2022 | 0.56 | 0.01 | 1.82% | 0.55 | 0.57 | 0.53 |
Jan 18, 2022 | 0.55 | -0.03 | -5.17% | 0.58 | 0.59 | 0.55 |
Jan 14, 2022 | 0.59 | 0.03 | 5.36% | 0.56 | 0.60 | 0.56 |
Jan 13, 2022 | 0.57 | 0.00 | 0.00% | 0.57 | 0.58 | 0.56 |
Jan 12, 2022 | 0.58 | -0.02 | -3.33% | 0.60 | 0.60 | 0.57 |
Jan 11, 2022 | 0.59 | 0.02 | 3.51% | 0.57 | 0.60 | 0.56 |
Jan 10, 2022 | 0.57 | -0.01 | -1.72% | 0.58 | 0.59 | 0.55 |
Jan 7, 2022 | 0.58 | -0.01 | -1.69% | 0.59 | 0.62 | 0.58 |
Jan 6, 2022 | 0.59 | -0.03 | -4.84% | 0.62 | 0.62 | 0.57 |
Jan 5, 2022 | 0.62 | -0.04 | -6.06% | 0.66 | 0.66 | 0.62 |
Jan 4, 2022 | 0.66 | 0.03 | 4.76% | 0.63 | 0.67 | 0.62 |
Jan 3, 2022 | 0.63 | 0.05 | 8.62% | 0.58 | 0.63 | 0.58 |
Dec 31, 2021 | 0.58 | -0.01 | -1.69% | 0.59 | 0.60 | 0.58 |
Dec 29, 2021 | 0.65 | 0.00 | 0.00% | 0.65 | 0.66 | 0.63 |
Dec 28, 2021 | 0.66 | 0.01 | 1.54% | 0.65 | 0.67 | 0.65 |
Tyme Technologies, Inc. Events
Kellaaeg (UTC) (UTC) | Riik | Sündmus |
---|---|---|
No events scheduled |
- Aastas
- Kvartalis
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Kogutulu | 0 | 0 | 0 | 0 | 0 |
Kogu tegevuskulu | 25.5136 | 27.217 | 25.7604 | 31.7766 | 19.3599 |
Müük/Üldine/admin kulud, kokku | 9.6321 | 10.1855 | 12.8045 | 14.5862 | 10.5202 |
Uuringud ja arendus | 13.4441 | 17.0315 | 12.9559 | 14.7195 | 8.83966 |
Tulud majandustegevusest | -25.5136 | -27.217 | -25.7604 | -31.7766 | -19.3599 |
Intressitulud (kulu), muud tulud, neto | 1.88754 | -3.99045 | 3.75982 | 0.08256 | 0 |
Muud, neto | 0 | 2.2287 | 0 | -1.28913 | 0.39039 |
Netotulu enne makse | -23.6261 | -28.9788 | -22.0006 | -32.9831 | -18.9695 |
Netotulu pärast makse | -23.6261 | -28.9788 | -22.0006 | -32.9831 | -18.9695 |
Vähemuse intress | |||||
Netotulu enne erikulusid | -23.6261 | -28.9788 | -22.0006 | -32.9831 | -18.9695 |
Netotulu | -23.6261 | -28.9788 | -22.0006 | -32.9831 | -18.9695 |
Arvestatav tulu, v a erikulud | -23.6261 | -28.9788 | -22.0006 | -32.9831 | -18.9695 |
Arvestatav tulu, koos erikuludega | -23.6261 | -28.9788 | -22.0006 | -32.9831 | -18.9695 |
Jaotamisele kuuluv netotulu | -23.6261 | -28.9788 | -22.0006 | -32.9831 | -18.9695 |
Keskmine jaotamisele kuuluv aktsia kohta | 172.207 | 134.251 | 114.533 | 102.354 | 90.5675 |
Jaotatav EPS, v a erakorralised kulud | -0.1372 | -0.21586 | -0.19209 | -0.32225 | -0.20945 |
Jaotamisele kuuluv normaal-EPS | -0.12304 | -0.21586 | -0.19209 | -0.2981 | -0.20945 |
Ootamatud kulutused (tulu) | 2.43738 | 0 | 2.47091 | ||
Tulu | 0 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Kogutulu | 0 | 0 | 0 | 0 | 0 |
Kogu tegevuskulu | 7.04492 | 5.88758 | 5.92852 | 6.65257 | 6.25254 |
Müük/Üldine/admin kulud, kokku | 2.30655 | 2.42429 | 2.4331 | 2.46816 | 2.1928 |
Uuringud ja arendus | 2.30099 | 3.46328 | 3.49542 | 4.18441 | 4.05974 |
Tulud majandustegevusest | -7.04492 | -5.88758 | -5.92852 | -6.65257 | -6.25254 |
Intressitulud (kulu), muud tulud, neto | 0.23041 | 0.56991 | 0.3638 | 0.70388 | -0.92916 |
Muud, neto | 0 | 0 | 0 | 0.01952 | 0 |
Netotulu enne makse | -6.81451 | -5.31766 | -5.56471 | -5.92916 | -7.1817 |
Netotulu pärast makse | -6.81451 | -5.31766 | -5.56471 | -5.92916 | -7.1817 |
Netotulu enne erikulusid | -6.81451 | -5.31766 | -5.56471 | -5.92916 | -7.1817 |
Netotulu | -6.81451 | -5.31766 | -5.56471 | -5.92916 | -7.1817 |
Arvestatav tulu, v a erikulud | -6.81451 | -5.31766 | -5.56471 | -5.92916 | -7.1817 |
Arvestatav tulu, koos erikuludega | -6.81451 | -5.31766 | -5.56471 | -5.92916 | -7.1817 |
Jaotamisele kuuluv netotulu | -6.81451 | -5.31766 | -5.56471 | -5.92916 | -7.1817 |
Keskmine jaotamisele kuuluv aktsia kohta | 172.207 | 172.207 | 172.207 | 172.205 | 154.169 |
Jaotatav EPS, v a erakorralised kulud | -0.03957 | -0.03088 | -0.03231 | -0.03443 | -0.04658 |
Jaotamisele kuuluv normaal-EPS | -0.02542 | -0.03088 | -0.03231 | -0.03443 | -0.04658 |
Tulu | 0 | 0 | 0 | 0 | |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | ||
Ootamatud kulutused (tulu) | 2.43738 |
- Aastas
- Kvartalis
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Käibevarad kokku | 78.8963 | 109.657 | 28.0793 | 16.1391 | 29.7084 |
Raha ja lühiajalised investeeringud | 74.3509 | 107.516 | 26.7004 | 14.3023 | 28.9758 |
Raha ja ekvivalendid | 13.7389 | 107.516 | 26.7004 | 14.3023 | 28.9758 |
Prepaid Expenses | 4.54539 | 2.14044 | 1.37891 | 1.83679 | 0.73256 |
Total Assets | 88.0152 | 110.263 | 29.5008 | 17.5166 | 31.0178 |
Property/Plant/Equipment, Total - Net | 0.03823 | 0.07547 | 0.15548 | 0.01036 | 0.00324 |
Property/Plant/Equipment, Total - Gross | 0.03701 | 0.03701 | 0.02146 | ||
Accumulated Depreciation, Total | -0.03701 | -0.03183 | -0.01822 | ||
Total Current Liabilities | 7.3857 | 5.64379 | 5.58179 | 6.21314 | 4.54587 |
Payable/Accrued | 3.4725 | 3.60228 | 2.66661 | 3.33043 | 2.62407 |
Notes Payable/Short Term Debt | 0 | 0 | 0.51812 | 0.59734 | 0.48009 |
Other Current Liabilities, Total | 2.94278 | 0.96613 | 0.54141 | 0.79012 | 0.19303 |
Total Liabilities | 7.93175 | 8.46767 | 10.4757 | 7.84877 | 4.54587 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Total Equity | 80.0834 | 101.796 | 19.0251 | 9.66788 | 26.472 |
Redeemable Preferred Stock | 0 | 0 | 0 | ||
Common Stock | 0.01722 | 0.01722 | 0.01233 | 0.0104 | 0.01013 |
Additional Paid-In Capital | 241.031 | 238.572 | 126.828 | 95.4722 | 79.2934 |
Retained Earnings (Accumulated Deficit) | -160.42 | -136.794 | -107.815 | -85.8147 | -52.8316 |
Other Equity, Total | -0.54426 | ||||
Total Liabilities & Shareholders’ Equity | 88.0152 | 110.263 | 29.5008 | 17.5166 | 31.0178 |
Total Common Shares Outstanding | 172.207 | 172.201 | 123.312 | 103.946 | 101.226 |
Other Long Term Assets, Total | 0 | 0.53099 | 1.26603 | 1.36717 | 1.30623 |
Accrued Expenses | 0.97041 | 1.07537 | 1.85564 | 1.49525 | 1.24869 |
Other Liabilities, Total | 0.54606 | 2.82389 | 4.89391 | 1.63563 | |
Lühiajalised investeeringud | 60.612 | ||||
Long Term Investments | 9.08067 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Käibevarad kokku | 78.8963 | 76.5475 | 77.3799 | 74.6885 | 109.657 |
Raha ja lühiajalised investeeringud | 74.3509 | 75.0594 | 75.5104 | 72.6232 | 107.516 |
Raha ja ekvivalendid | 13.7389 | 20.8022 | 29.2156 | 36.4589 | 107.516 |
Prepaid Expenses | 4.54539 | 1.48811 | 1.86946 | 2.06523 | 2.14044 |
Total Assets | 88.0152 | 93.0008 | 97.8066 | 103.098 | 110.263 |
Property/Plant/Equipment, Total - Net | 0.03823 | 0.04796 | 0.0574 | 0.06656 | 0.07547 |
Property/Plant/Equipment, Total - Gross | 0.03701 | ||||
Accumulated Depreciation, Total | -0.03701 | ||||
Other Long Term Assets, Total | 0 | 0 | 0 | 0 | 0.53099 |
Total Current Liabilities | 7.3857 | 5.45268 | 4.77251 | 4.63152 | 5.64379 |
Payable/Accrued | 3.4725 | 3.67264 | 3.2426 | 3.44197 | 3.60228 |
Accrued Expenses | 0.97041 | 1.15187 | 0.78008 | 0.40833 | 1.07537 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 2.94278 | 0.62817 | 0.74982 | 0.78122 | 0.96613 |
Total Liabilities | 7.93175 | 6.31038 | 6.29734 | 6.61569 | 8.46767 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Liabilities, Total | 0.54606 | 0.8577 | 1.52484 | 1.98416 | 2.82389 |
Total Equity | 80.0834 | 86.6904 | 91.5093 | 96.4825 | 101.796 |
Redeemable Preferred Stock | 0 | 0 | 0 | 0 | |
Common Stock | 0.01722 | 0.01722 | 0.01722 | 0.01722 | 0.01722 |
Additional Paid-In Capital | 241.031 | 240.443 | 239.839 | 239.222 | 238.572 |
Retained Earnings (Accumulated Deficit) | -160.42 | -153.606 | -148.288 | -142.723 | -136.794 |
Total Liabilities & Shareholders’ Equity | 88.0152 | 93.0008 | 97.8066 | 103.098 | 110.263 |
Total Common Shares Outstanding | 172.207 | 172.207 | 172.207 | 172.207 | 172.201 |
Lühiajalised investeeringud | 60.612 | 54.2573 | 46.2948 | 36.1644 | |
Long Term Investments | 9.08067 | 16.4053 | 20.3694 | 28.3431 | |
Other Equity, Total | -0.54426 | -0.1642 | -0.05856 | -0.03384 |
- Aastas
- Kvartalis
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Netotulu/algväärtus | -23.6261 | -28.9788 | -22.0006 | -32.9831 | -18.9695 |
Raha majandustegevusest | -21.2428 | -23.5645 | -19.5603 | -20.1161 | -11.8793 |
Raha majandustegevusest | 0 | 0.00518 | 0.00518 | 0.00842 | 0.0043 |
Mittelikviidsed varad | 2.26121 | 5.14359 | 2.44107 | 10.2408 | 7.29895 |
Cash Taxes Paid | 0 | 0 | 0 | 0 | 0 |
Makstud intressid | 0.07024 | 0.09713 | 0.11424 | 0.00742 | 0 |
Muutused tööjõus | 0.12209 | 0.26551 | -0.00601 | 2.61781 | -0.21301 |
Tulu investeeringutelt | -72.5409 | 0 | -0.01554 | ||
Kapitalikulutused | 0 | -0.01554 | |||
Rahavood investeeringutelt | 0.00619 | 104.38 | 31.9584 | 5.45815 | 30.3721 |
Rahavoogudesse investeerimine | 0 | 0.175 | |||
Aktsiate emiteerimine (tagasiost), neto | 0.00619 | 104.899 | 32.5557 | 5.93824 | 30.1971 |
Laenu väljastamine (kustutamine), neto | 0 | -0.51812 | -0.59734 | -0.48009 | 0 |
Rahaline kogumuutus | -93.7775 | 80.816 | 12.3981 | -14.6735 | 18.4928 |
Muud rahavood investeeringutelt, kokku | -72.5409 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | -23.6261 | -16.8115 | -11.4939 | -5.92916 | -28.9788 |
Cash From Operating Activities | -21.2428 | -14.0354 | -10.2803 | -5.80934 | -23.5645 |
Cash From Operating Activities | 0 | 0 | 0 | 0 | 0.00518 |
Non-Cash Items | 2.26121 | 1.43436 | 0.91297 | 0.14583 | 5.14359 |
Cash Taxes Paid | 0 | 0 | 0 | 0 | 0 |
Cash Interest Paid | 0.07024 | 0.05693 | 0.04063 | 0.02126 | 0.09713 |
Changes in Working Capital | 0.12209 | 1.34173 | 0.30056 | -0.026 | 0.26551 |
Cash From Financing Activities | 0.00619 | 0.00619 | 0.00619 | 0.00619 | 104.38 |
Issuance (Retirement) of Stock, Net | 0.00619 | 0.00619 | 0.00619 | 0.00619 | 104.899 |
Issuance (Retirement) of Debt, Net | 0 | 0 | 0 | 0 | -0.51812 |
Net Change in Cash | -93.7775 | -86.7143 | -78.3008 | -71.0576 | 80.816 |
Cash From Investing Activities | -72.5409 | -72.685 | -68.0266 | -65.2544 | |
Other Investing Cash Flow Items, Total | -72.5409 | -72.685 | -68.0266 | -65.2544 | |
Financing Cash Flow Items | 0 |
Miks valida Capital.com? Meie numbrid räägivad iseenda eest.
Capital.com Group500K+
Kauplejad
92K+
Igakuiste aktiivsete klientide arv
$53M+
Igakuine investeerimise maht
$30M+
Igakuiselt välja võetud
Kauplemiskalkulaator
Arvutage oma hüpoteetiline võit/kaotus, kui oleksite avanud CFD-tehingu ühel kindlal kuupäeval (valige kuupäev) ja sulgenud teisel kuupäeval (valige kuupäev).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Tyme Technologies, Inc. Company profile
Ettevõttest Tyme Technologies, Inc.
Tyme Technologies, Inc. on biotehnoloogia ettevõte. Ettevõte keskendub vähi metabolismil põhinevate ravimeetodite (CMBT) arendamisele erinevate soliidsete kasvajate ja hematoloogiliste vähivormide puhul. Ettevõtte juhtiv kliiniline CMBT ühend SM-88 on suukaudne uuritav modifitseeritud türosiini derivaat, mis eeldatavasti katkestab vähirakkude ainevahetusprotsesse, lõhkudes raku peamisi kaitsevahendeid ja põhjustades oksüdatiivse stressi ja organismi loomuliku immuunsüsteemi kokkupuute kaudu rakusurma. Samuti arendatakse SM-88i, SM-88i süstitavat ravimvormi mitmete onkoloogiliste näidustuste raviks. TYME-18 on prekliiniline CMBT, mis on mõeldud ravimi rakusiseseks manustamiseks ja vähirakkude läbilaskvuse suurendamiseks, pakkudes samal ajal ravi, millel on selektiivne tsütotoksiline toime kasvaja suhtes. TYME-19 on suukaudne sünteetiliselt toodetud sapphapete perekonna liige, mida töötatakse välja COVID-19 võimalikuks raviks.
Industry: | Bio Therapeutic Drugs |
1 Pluckemin Way - Suite 103
07921
Tuluaruanne
- Annual
- Quarterly
Teised on vaadanud veel
Kas otsite jätkuvalt vahendajat, keda saab usaldada?
Ühinege 500,000+ kauplejaga üle kogu maailma, kes valisid kauplemiseks veebisaidi Capital.com